Showing results (451-460 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|May 8, 2009
Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRAAntoine Pariente, Amélie Daveluy, Anne Laribière-Bénard, et al.Drug Safety|September 15, 2006
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in EnglandDeborah Layton, Lynda Wilton, Andrew Boshier, et al.Drug Safety|March 9, 2007
The Erice Manifesto: for global reform of the safety of medicines in patient careDrug Safety|March 9, 2007
Drug-induced endocrine and metabolic disordersRonald C W Ma, Alice P S Kong, Norman Chan, et al.Drug Safety|March 9, 2007
Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP surveyOlivia Boeuf, Maryse Lapeyre-Mestre, Drug Safety|December 30, 2006
A population-based case-control teratologic study of oral dipyrone treatment during pregnancyFerenc Bánhidy, Nándor Acs, Erzsébet Puhó, et al.Drug Safety|July 3, 2007
Negative effects of antiepileptic drugs on mood in patients with epilepsyMarco Mula, Josemir W SanderDrug Safety|July 3, 2007
Standardised MedDRA queries: their role in signal detectionPatricia MozzicatoDrug Safety|July 3, 2007
Signal detection in the pharmaceutical industry: integrating clinical and computational approachesManfred HaubenDrug Safety|June 18, 2009
Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in CanadaVincent Nichols, Isabelle Thériault-Dubé, Julie Touzin, et al.Pageof 308